Last reviewed · How we verify
NCT05623293
Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis
trial testing eye - Optcial coherence tomography in Choroid Disease in 40 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Universidade do Porto |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 January 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- eye - Optcial coherence tomography
Conditions studied
- Choroid Disease — all drugs for Choroid Disease →
- Carotid Stenosis — all drugs for Carotid Stenosis →
- Carotid Atherosclerosis — all drugs for Carotid Atherosclerosis →
- Retinal Disease — all drugs for Retinal Disease →
Sponsor
Universidade do Porto — full company profile →
Who can join
18 and older, any sex, with Choroid Disease or Carotid Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The retinal vessels have been shown to reflect vascular changes inherent to systemic pathologies, even when no ocular disease is identified. As such, the eye's vasculature is ableto serve as a window to the vascular health of the human body and a means of assessing systemic endothelial function. Optical coherence tomography angiography (OCTA) employs optical means to image all the retinal vascular layers and the choroid, providing an extremely detailed image of the microvascular network in a fast, reproducible and totally non-invasive way. As such, it is currently the best non-invasive way of having an image of human capillaries. Recently, OCTA has been used to study the retinal vessels' structure and function in several cardiovascular diseases. As an example of its predictive potential, reduced retinal microvascular density has been associated with the cardiovascular risk profile in patients admitted to the hospital for an acute coronary syndrome. Recent studies have also shown the retinal microvasculature density to be reduced in patients with carotid artery disease (CAD), namely carotid stenosis, and that endarterectomy increases retinal flow and vessel density.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Association of Radiomics and Pericarotid Adipose Tissue Characteristics with Systemic Inflammation in Patients Undergoing Carotid Endarterectomy.
Santos-Teixeira D, Myrcha P, Trigo V, Ribeiro H, et al · · 2025 · PMID 41375644 · DOI 10.3390/jcm14238342
Verify or expand the search:
- PubMed search for NCT05623293
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Universidade do Porto trials
Trials by the same sponsor.
- NCT07457697 — MyGENESIS: A Digital Psychoeducational Program for Donor-Conceived Young Adults · NA · not yet recruiting
- NCT07503990 — Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance · NA · recruiting
- NCT07436091 — Porcine Derma for Soft Tissue Augmentation Around Implants · NA · not yet recruiting
- NCT07498556 — Immediate Restoration of a New Implant With High Primary Stability · NA · not yet recruiting
- NCT07448870 — Evaluating the Mentalization-based Treatment Lighthouse Parenting Programme: Protocol of a Feasibility and Acceptability · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05623293 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade do Porto
- Last refreshed: 21 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05623293.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing